Delivery Order SPE2DB25D3504-SPE2DB25FVTFE

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $12,754.00 to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award was issued by the Defense Logistics Agency (DLA) and is a Delivery Order contract for Atovaquone-Proguanil 250-100 100s, a prescription medication. The contract has an ultimate completion date of July 19, 2024 and is a Firm Fixed Price contract. This award is likely part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $73,404 for the supply of Atovaquone-Proguanil 250-100 100s medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Atovaquone-Proguanil 250-100 mg tablets. The contract, valued at $25,807.93, is a firm-fixed-price delivery order with an ultimate completion date of August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,360.00 fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Atovaquone-Proguanil 250-100 medication in 100-count packages. The $9,446.27 firm fixed-price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,615.27 firm fixed price delivery order is for the supply of 100 units of Atovaquone-Proguanil 250-100 medication, with a completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order valued at $2,927.14 for the supply of 4,566,488,958 units of atovaquone-proguanil 250-100 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 20, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $1,032.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Atovaquone-Proguanil 250-100 UD 24S. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,733.47 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 UD 24S, a pharmaceutical product. The contract has a period of performance through March 12, 2024 and was awarded on March 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 medication to the Defense Logistics Agency (DLA). The $1,002.18 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVTFE
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of atovaquone-proguanil 250-100 100s medication. The $2,943.11 firm fixed-price delivery order has a completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 4/30/25, 10:15 AM